UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 43 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 1,663 | +20.1% | 0.00% | – |
Q2 2022 | $1,000 | -92.3% | 1,385 | -88.8% | 0.00% | – |
Q1 2022 | $13,000 | +550.0% | 12,335 | +824.0% | 0.00% | – |
Q4 2021 | $2,000 | -71.4% | 1,335 | -44.3% | 0.00% | – |
Q3 2021 | $7,000 | -83.3% | 2,395 | -73.2% | 0.00% | – |
Q2 2021 | $42,000 | +7.7% | 8,943 | +36.4% | 0.00% | – |
Q1 2021 | $39,000 | +30.0% | 6,557 | +15.2% | 0.00% | – |
Q4 2020 | $30,000 | +275.0% | 5,692 | +154.7% | 0.00% | – |
Q3 2020 | $8,000 | -75.0% | 2,235 | -39.4% | 0.00% | – |
Q2 2020 | $32,000 | +113.3% | 3,686 | +52.8% | 0.00% | – |
Q1 2020 | $15,000 | -31.8% | 2,413 | -19.8% | 0.00% | – |
Q4 2019 | $22,000 | +83.3% | 3,008 | +50.4% | 0.00% | – |
Q3 2019 | $12,000 | -36.8% | 2,000 | 0.0% | 0.00% | – |
Q2 2019 | $19,000 | +216.7% | 2,000 | +150.0% | 0.00% | – |
Q1 2019 | $6,000 | -53.8% | 800 | 0.0% | 0.00% | – |
Q4 2018 | $13,000 | -18.8% | 800 | -20.3% | 0.00% | – |
Q3 2018 | $16,000 | +33.3% | 1,004 | +22.1% | 0.00% | – |
Q2 2018 | $12,000 | – | 822 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
Leap Investments LP | 13,400 | $78,000 | 0.11% |
Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |